Chen Qiankun, Li Hua, Liu Ji
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, P.R. China.
Department of Anesthesiology, Shanghai Pulmonary Hospital, Shanghai 200433, P.R. China.
Oncol Lett. 2021 Oct;22(4):722. doi: 10.3892/ol.2021.12983. Epub 2021 Aug 10.
To the best of our knowledge, the oncogenic role of circular RNA solute carrier family 26 member 4 (circSLC26A4) has only been reported in cervical cancer, while its role in non-small cell lung cancer (NSCLC) is unknown. The present study explored the involvement of circSLC26A4 in NSCLC. NSCLC tissues and paired adjacent non-tumor tissues were collected from 64 patients with NSCLC. The expression levels of circSLC26A4, mature microRNA-15a (miR-15a) and miR-15a precursor in these tissues were determined by reverse transcription-quantitative PCR (RT-qPCR). NSCLC cells were transfected with pcDNA3.1-circSLC26A4 vector to overexpress circSLC26A4, followed by the measurement of the expression levels of mature miR-15a and miR-15a precursor using RT-qPCR. Cell proliferation was analyzed using a Cell Counting Kit-8 assay. circSLC26A4 expression was upregulated in NSCLC tissues, and its high expression was significantly associated with poor survival of patients with NSCLC. The expression levels of circSLC26A4 were correlated with the expression levels of mature miR-15a, but not the expression levels of miR-15a precursor in NSCLC tissues. In NSCLC cells, overexpression of circSLC26A4 was associated with downregulation of mature miR-15a expression, but not miR-15a precursor expression. A cell proliferation assay revealed that overexpression of circSLC26A4 reduced the inhibitory effects of overexpression of miR-15a on cell proliferation. Therefore, circSLC26A4 may suppress the maturation of miR-15a in NSCLC to inhibit cancer cell proliferation.
据我们所知,环状RNA溶质载体家族26成员4(circSLC26A4)的致癌作用仅在宫颈癌中被报道,而其在非小细胞肺癌(NSCLC)中的作用尚不清楚。本研究探讨了circSLC26A4在NSCLC中的作用。从64例NSCLC患者中收集NSCLC组织及配对的相邻非肿瘤组织。采用逆转录定量PCR(RT-qPCR)检测这些组织中circSLC26A4、成熟微小RNA-15a(miR-15a)和miR-15a前体的表达水平。用pcDNA3.1-circSLC26A4载体转染NSCLC细胞以过表达circSLC26A4,随后用RT-qPCR检测成熟miR-15a和miR-15a前体的表达水平。使用细胞计数试剂盒-8法分析细胞增殖。circSLC26A4在NSCLC组织中表达上调,其高表达与NSCLC患者的不良生存显著相关。NSCLC组织中circSLC26A4的表达水平与成熟miR-15a的表达水平相关,但与miR-15a前体的表达水平无关。在NSCLC细胞中,circSLC26A4的过表达与成熟miR-15a表达的下调相关,但与miR-15a前体表达无关。细胞增殖试验表明,circSLC26A4的过表达降低了miR-15a过表达对细胞增殖的抑制作用。因此,circSLC26A4可能通过抑制NSCLC中miR-15a的成熟来抑制癌细胞增殖。